Literature DB >> 25422074

Sex- and gender-specific research priorities for the emergency management of heart failure and acute arrhythmia: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup.

Alyson J McGregor1, W Frank Peacock, Anna Marie Chang, Basmah Safdar, Deborah Diercks.   

Abstract

The emergency department (ED) is the point of first contact for patients with acute heart failure and arrhythmias, with 1 million annual ED visits in the United States. Although the total numbers of men and women living with heart failure are similar, female patients are underrepresented in clinical studies, with current knowledge predominantly based on data from male patients. This has led to an underappreciation of the sex-specific differences in clinical characteristics and pathophysiology-based management of heart failure. Similar disparities have been found in management of acute arrhythmias, especially atrial arrhythmias that lead to an increased risk of stroke in women. Additionally, peripartum and postpartum cardiomyopathy represent a diagnostic and treatment dilemma. This article is the result of a breakout session in the cardiovascular and resuscitation work group of the 2014 Academic Emergency Medicine consensus conference "Gender-Specific Research in Emergency Medicine: Investigate, Understand, and Translate How Gender Affects Patient Outcomes." A nominal group technique was used to identify and prioritize themes and research questions using electronic mail, monthly conference calls, in-person meetings, and Web-based surveys between June 2013 and May 2014. Consensus was achieved through three rounds of nomination followed by the meeting on May 13, 2014, and resulted in seven priority themes that are essential to the common complex clinical syndrome of heart failure for both men and women and include the areas of pathophysiology; presentation and symptomatology; and diagnostic strategies using biomarkers, treatment, and mortality, with special consideration to arrhythmia management and pregnancy.
© 2014 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25422074      PMCID: PMC4284822          DOI: 10.1111/acem.12526

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  81 in total

1.  Survival advantage from ventricular fibrillation and pulseless electrical activity in women compared to men: the Oregon Sudden Unexpected Death Study.

Authors:  Carmen Teodorescu; Kyndaron Reinier; Audrey Uy-Evanado; Jo Ayala; Ronald Mariani; Lynn Wittwer; Karen Gunson; Jonathan Jui; Sumeet S Chugh
Journal:  J Interv Card Electrophysiol       Date:  2012-03-11       Impact factor: 1.900

2.  Gender differences of bleeding and stroke risk in very old atrial fibrillation patients on VKA treatment: results of the EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).

Authors:  Daniela Poli; Emilia Antonucci; Sophie Testa; Walter Ageno; Gualtiero Palareti
Journal:  Thromb Res       Date:  2012-11-08       Impact factor: 3.944

3.  Gender does not affect postdischarge outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan [EVEREST] Trial).

Authors:  Ami N Shah; Robert J Mentz; Mihai Gheorghiade; Mary J Kwasny; Angela J Fought; Faiez Zannad; Karl Swedberg; Aldo P Maggioni; Marvin A Konstam
Journal:  Am J Cardiol       Date:  2012-09-19       Impact factor: 2.778

4.  Sex-specific acute heart failure phenotypes and outcomes from PROTECT.

Authors:  Sven Meyer; Peter van der Meer; Barry M Massie; Christopher M O'Connor; Marco Metra; Piotr Ponikowski; John R Teerlink; Gad Cotter; Beth A Davison; John G F Cleland; Michael M Givertz; Daniel M Bloomfield; Mona Fiuzat; Howard C Dittrich; Hans L Hillege; Adriaan A Voors
Journal:  Eur J Heart Fail       Date:  2013-12       Impact factor: 15.534

5.  Mechanisms of diastolic dysfunction in heart failure with a preserved ejection fraction: If it's not one thing it's another.

Authors:  Martin M LeWinter; Markus Meyer
Journal:  Circ Heart Fail       Date:  2013-11       Impact factor: 8.790

6.  Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.

Authors:  Frank Edelmann; Rolf Wachter; Albrecht G Schmidt; Elisabeth Kraigher-Krainer; Caterina Colantonio; Wolfram Kamke; André Duvinage; Raoul Stahrenberg; Kathleen Durstewitz; Markus Löffler; Hans-Dirk Düngen; Carsten Tschöpe; Christoph Herrmann-Lingen; Martin Halle; Gerd Hasenfuss; Götz Gelbrich; Burkert Pieske
Journal:  JAMA       Date:  2013-02-27       Impact factor: 56.272

7.  Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia.

Authors:  Kumar Dharmarajan; Angela F Hsieh; Zhenqiu Lin; Héctor Bueno; Joseph S Ross; Leora I Horwitz; José Augusto Barreto-Filho; Nancy Kim; Susannah M Bernheim; Lisa G Suter; Elizabeth E Drye; Harlan M Krumholz
Journal:  JAMA       Date:  2013-01-23       Impact factor: 56.272

8.  Effects of carvedilol on heart failure with preserved ejection fraction: the Japanese Diastolic Heart Failure Study (J-DHF).

Authors:  Kazuhiro Yamamoto; Hideki Origasa; Masatsugu Hori
Journal:  Eur J Heart Fail       Date:  2012-09-14       Impact factor: 15.534

9.  Relationship between sex, ejection fraction, and B-type natriuretic peptide levels in patients hospitalized with heart failure and associations with inhospital outcomes: findings from the Get With The Guideline-Heart Failure Registry.

Authors:  Eileen M Hsich; Maria V Grau-Sepulveda; Adrian F Hernandez; Zubin J Eapen; Ying Xian; Lee H Schwamm; Deepak L Bhatt; Gregg C Fonarow
Journal:  Am Heart J       Date:  2013-10-22       Impact factor: 4.749

10.  Comparable performance of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with preserved and reduced ejection fraction.

Authors:  Susan M Joseph; Eric Novak; Suzanne V Arnold; Philip G Jones; Himad Khattak; Anne E Platts; Victor G Dávila-Román; Douglas L Mann; John A Spertus
Journal:  Circ Heart Fail       Date:  2013-10-15       Impact factor: 8.790

View more
  3 in total

1.  Elevated renalase levels in patients with acute coronary microvascular dysfunction - A possible biomarker for ischemia.

Authors:  Basmah Safdar; Xiaojia Guo; Caitlin Johnson; Gail D'Onofrio; James Dziura; Albert J Sinusas; Jeffrey Testani; Veena Rao; Gary Desir
Journal:  Int J Cardiol       Date:  2019-01-02       Impact factor: 4.164

2.  Readmission rates following heart failure: a scoping review of sex and gender based considerations.

Authors:  Amy Hoang-Kim; Camilla Parpia; Cassandra Freitas; Peter C Austin; Heather J Ross; Harindra C Wijeysundera; Karen Tu; Susanna Mak; Michael E Farkouh; Louise Y Sun; Michael J Schull; Robin Mason; Douglas S Lee; Paula A Rochon
Journal:  BMC Cardiovasc Disord       Date:  2020-05-14       Impact factor: 2.298

3.  Sex differences in factors associated with heart failure and diastolic left ventricular dysfunction: a cross-sectional population-based study.

Authors:  Giulia Cesaroni; Gian Francesco Mureddu; Nera Agabiti; Flavia Mayer; Massimo Stafoggia; Francesco Forastiere; Roberto Latini; Serge Masson; Marina Davoli; Alessandro Boccanelli
Journal:  BMC Public Health       Date:  2021-02-27       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.